# 3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension

> **NCT06205992** · — · RECRUITING · sponsor: **Shengjing Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Cirrhosis
- Liver Portal Hypertension

## Interventions

- **DEVICE:** 3D-MRE
- **DEVICE:** HVPG
- **DEVICE:** 2D-MRE
- **DEVICE:** HVPG

## Key facts

- **NCT ID:** NCT06205992
- **Lead sponsor:** Shengjing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-16
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06205992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06205992, "3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06205992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*